COX JOHN (CEO & President) sold 0.7% of their position (2.73K shares) of DYNE THERAPEUTICS, INC. on the open market
Open‑market sale worth $40.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/6/2026ACC: 0001193125-26-096512
DirectorOfficer· CEO & President
Since Mar 2026
-2.73K
Net shares
Net seller
$40.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.73K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.73K
Price / share
$14.90
Trade value
$40.71K
% of position
0.7%
3/5/2026
376.88K→374.14K
Total
Net shares
−2.73K
Net value
-$40.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2026 | S · Sale | −2.73K | $14.90 | $40.71K | 0.7% | 376.88K | 374.14K |
| Total | −2.73K | -$40.71K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned18K
Common Stock
IndirectShares owned18K
Common Stock
IndirectShares owned18K
Common Stock
IndirectShares owned18K
Total
72K indirect72K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 18K | Indirect |
| Common Stock | 18K | Indirect |
| Common Stock | 18K | Indirect |
| Common Stock | 18K | Indirect |
| Total | 72K | 72K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported